Role of Therapeutic Plasmapheresis in SARS-CoV-2 Induced Cytokine Release Syndrome: A Retrospective Cohort Study on COVID-19 Patients

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. Accessed April 11, 2022. https://covid19.who.int/
   Google Scholar
• Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Reports. 2021;17(1):163–175. doi:10.1007/S12015-020-09994-5/TABLES/1
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chen D, Cai D, Yi Y, Jiang S. Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: a network meta-analysis. J Med Virol. 2021;93(2):1171–1174. doi:10.1002/JMV.26443
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826. doi:10.1056/NEJMOA2007764
   PubMed Web of Science ®Google Scholar
• Young B, Tan TT, Leo YS. The place for remdesivir in COVID-19 treatment. Lancet Infect Dis. 2021;21(1):20–21. doi:10.1016/S1473-3099(20)30911-7
   PubMed Web of Science ®Google Scholar
• Merad M, Subramanian A, Wang TT. An aberrant inflammatory response in severe COVID-19. Cell Host Microbe. 2021;29(7):1043–1047. doi:10.1016/J.CHOM.2021.06.018
   PubMed Web of Science ®Google Scholar
• Li X, Shao M, Zeng X, Qian P, Huang H. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal Transduct Target Ther. 2021;6(1):1–16. doi:doi:10.1038/s41392-021-00764-4
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255–2273. doi:doi:10.1056/NEJMRA2026131
   PubMed Web of Science ®Google Scholar
• Memish ZA, Faqihi F, Alharthy A, Alqahtani SA, Karakitsos D. Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives. Int J Antimicrob Agents. 2021;57(2):106273. doi:doi:10.1016/J.IJANTIMICAG.2020.106273
   PubMed Web of Science ®Google Scholar
• Kaplan AA. Therapeutic plasma exchange: a technical and operational review. J Clin Apher. 2013;28(1):3–10. doi:doi:10.1002/JCA.21257
   PubMed Web of Science ®Google Scholar
• Keith PD, Wells AH, Hodges J, Fast SH, Adams A, Scott LK. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience. Crit Care. 2020;24(1):1. doi:doi:10.1186/S13054-020-03241-6
   PubMed Web of Science ®Google Scholar
• Knaup H, Stahl K, Schmidt BMW, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22:1. doi:doi:10.1186/S13054-018-2220-9
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130(4):1545–1548. doi:doi:10.1172/JCI138003
   PubMed Web of Science ®Google Scholar
• Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. Available from: https://jamanetwork.com/journals/jama/article-abstract/2763983. Accessed December 6, 2021.
   Google Scholar
• Alharthy A, Faqihi F, Balhamar A, Memish ZA, Karakitsos D. Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: a case series. SAGE Open Med Case Reports. 2020;8:2050313X20964089. doi:doi:10.1177/2050313X20964089
   PubMed Web of Science ®Google Scholar
• Faqihi F, Alharthy A, Memish ZA, Kutsogiannis DJ, Brindley PG, Karakitsos D. Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange. Clin Case Reports. 2020;8(12):3233–3238. doi:doi:10.1002/CCR3.3397
   Web of Science ®Google Scholar
• Dogan L, Kaya D, Sarikaya T, et al. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series. Brain Behav Immun. 2020;87:155–158. doi:doi:10.1016/J.BBI.2020.05.022
   PubMed Web of Science ®Google Scholar
• National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin Med J. 2020;133(9):1087. doi:doi:10.1097/CM9.0000000000000819
   PubMed Web of Science ®Google Scholar
• Clinical Management Protocol Covid-19. Guidelines Clinical Management Guidelines for COVID-19 Infections; 2020. Available from: https://covid.gov.pk/new_guidelines/5.June.2020_Clinical_Management_Guidelines_for_COVID-19_infection_v3_cleaned_1-6-20_for_submission.pdf. Accessed December 10, 2021.
   Google Scholar
• Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis. 2013;5(3):326. doi:10.3978/J.ISSN.2072-1439.2013.04.05
   PubMed Web of Science ®Google Scholar
• Department Of Critical Care Clinical Guideline. Guidelines for therapeutic plasma exchange in critical care; 2016. Available from: https://www.bsuh.nhs.uk/library/wp-content/uploads/sites/8/2020/09/TPE.pdf. Accessed December 10, 2021.
   Google Scholar
• Kamran SM, Mirza ZE, Naseem A H, et al. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study. PLoS One. 2021;16(1):e0244853. doi:10.1371/JOURNAL.PONE.0244853
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Ng WH, Tipih T, Makoah NA, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. MBio. 2021;12(1):1–12. doi:10.1128/mBio.03647-20
   Web of Science ®Google Scholar
• Jamil Z, Khan AA, Khalid S, Asghar M, Muhammad K, Waheed Y. Beneficial effects of anticoagulants on the clinical outcomes of COVID-19 patients. Antibiot. 2021;10:1394. doi:10.3390/ANTIBIOTICS10111394
   Google Scholar
• Jamil Z, Khalid S, Abbasi SM, Waheed Y, Ahmed J. Clinical outcomes of moderate to severe COVID-19 patients receiving invasive vs. non-invasive ventilation. Asian Pac J Trop Med. 2021;14(4):176. doi:10.4103/1995-7645.312518
   Web of Science ®Google Scholar
• Lee PA, Weger GW, Pryor RW, Matson JR. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med. 1998;26(4):730–737. doi:10.1097/00003246-199804000-00024
   PubMed Web of Science ®Google Scholar